VBI Vaccines News, VBI Vaccines Quote, VBIV Quote

VBI Vaccines (NQ:VBIV) Delayed: 0.60 +0.01 (1.69%)

Prev. Close

$0.59

Open

$0.59

52 Wk High

$4.35

52 Wk Low

$1.76

Day High

$0.60

Day Low

$0.56

P/E

N/A

EPS

$0.00

Volume

123,634

Friends, Peers and Foes (?): BRIBY, 7SS, VIR ANTX (more...)

Apr 17, 2024 04:17 PM Form SC 13D/A VBI Vaccines Inc/BC Filed by: PERCEPTIVE ADVISORS LLC
Apr 16, 2024 08:07 AM Form 10-K VBI Vaccines Inc/BC For: Dec 31
Apr 16, 2024 08:03 AM VBI Vaccines Reports Full Year 2023 Financial Results
Apr 16, 2024 08:03 AM Form 8-K VBI Vaccines Inc/BC For: Apr 16
Apr 11, 2024 04:08 PM Form 8-K VBI Vaccines Inc/BC For: Apr 09
Apr 11, 2024 04:05 PM VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Apr 11, 2024 09:07 AM Form 424B5 VBI Vaccines Inc/BC
Apr 9, 2024 02:45 PM VBI Vaccines (VBIV) Announces $2 Million Registered Direct Offering Priced At-the-Market
Apr 9, 2024 02:45 PM VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Apr 3, 2024 08:02 AM VBI Vaccines (VBIV) Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma

Entities mentioned with VBIV